| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/02/2009 | US20090169575 Proteins |
| 07/02/2009 | US20090169574 Heteroclitic analogs and related methods |
| 07/02/2009 | US20090169573 T-Cell Stimulatory Peptides From The Melanoma-Associated Chondroitin Sulfate Proteoglycan And Their Use |
| 07/02/2009 | US20090169572 Methods for damaging cells using effector functions of anti-cdh3 antibodies |
| 07/02/2009 | US20090169569 APO-2L receptor agonist and CPT-11 synergism |
| 07/02/2009 | US20090169565 Neutrokine-alpha antibodies and methods of use thereof |
| 07/02/2009 | US20090169564 Stimulus Inducible Protein Kinase Complex and Methods of Use Therefor |
| 07/02/2009 | US20090169563 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 07/02/2009 | US20090169561 monoclonal antibodies that bind to interferon-inducible-protein-10 (IP-10, CXCL10); immune system disorders; autoimmune or inflammatory disorders |
| 07/02/2009 | US20090169556 Vascular endothelial cell growth factor antagonists |
| 07/02/2009 | US20090169555 Administering the kinase to regulate mitogenesis, apoptosis, neuronal development, chemotaxis, angiogenesis or an inflammatory response inclding developmental retardation, excessive apoptosis, cancer, restenosis and diabetic neuropathy; screening for drugs that stimulate or inhibit lipid phosphorylation |
| 07/02/2009 | US20090169554 Polypeptides of Leishmania Major and Polynucleotides Encoding Same and Vaccinal, Therapeutical and Diagnostic Applications Thereof |
| 07/02/2009 | US20090169553 Novel Protein Fusion/Tag Technology |
| 07/02/2009 | US20090169551 Methods and compositions for activating or inhibiting vegf-d and vegf-c |
| 07/02/2009 | US20090169549 Conformational isomers of alpha-synuclein, antibodies thereto and methods of their manufacture and use |
| 07/02/2009 | US20090169548 Binding molecules |
| 07/02/2009 | US20090169547 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 07/02/2009 | US20090169546 For inhibiting the release of a proinflammatory cytokine from a vertebrate cell; sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169542 Modulators of neuronal regeneration |
| 07/02/2009 | US20090169541 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor |
| 07/02/2009 | US20090169540 Use Of An Antagonist Of Epac For Treating Human Cardiac Hypertrophy |
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 07/02/2009 | DE19963612B4 Neue spannungsabhängige Kaliumkanäle aus der Kv4-Familie sowie deren Verwendung zur Entwicklung von Therapeutika New voltage-dependent potassium channels of the Kv4 family, as well as their use for the development of therapeutics |
| 07/02/2009 | CA2710483A1 Methods and agents for improving targeting of cd138 expressing tumor cells |
| 07/02/2009 | CA2710471A1 Immunoconjugates targeting cd138 and uses thereof |
| 07/02/2009 | CA2710453A1 Agents targeting cd138 and uses thereof |
| 07/02/2009 | CA2710347A1 Pm-2 antibodies and methods for treating metastasis |
| 07/02/2009 | CA2709675A1 Glycosyltransferases, polynucleotides encoding these and methods of use |
| 07/02/2009 | CA2709500A1 Type iii secretion system component protein pa1698 of pseudomonas aeruginosa |
| 07/02/2009 | CA2709430A1 Bivalent, bispecific antibodies |
| 07/02/2009 | CA2709347A1 Bivalent, bispecific antibodies |
| 07/02/2009 | CA2709345A1 Bivalent, bispecific antibodies |
| 07/02/2009 | CA2709029A1 Stability testing of antibodies |
| 07/02/2009 | CA2709023A1 Bivalent, bispecific antibodies |
| 07/02/2009 | CA2708871A1 Binding members for interleukin-4 receptor alpha (il-4ra) - 173 |
| 07/02/2009 | CA2708740A1 Hepatitis c virus antibodies |
| 07/02/2009 | CA2708407A1 Humanized anti-human cd34 antibody, the preparation method and uses thereof |
| 07/02/2009 | CA2708074A1 Non-aggregating human vh domains |
| 07/01/2009 | EP2075335A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/01/2009 | EP2075334A1 EG-VEGF nucleic acids and polypeptides and methods of use |
| 07/01/2009 | EP2075258A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 07/01/2009 | EP2075257A1 Preparation of antibody using mrl/lpr mouse |
| 07/01/2009 | EP2075256A2 Multispecific binding molecules |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2075253A1 Compositions and methds for the diagnosis and treatment of disorders involving angiogensis |
| 07/01/2009 | EP2074149A2 Compositions and methods relating to glucagon receptor antibodies |
| 07/01/2009 | EP2074148A1 Novel antiproliferation antibodies |
| 07/01/2009 | EP2074147A1 Antibodies against ccr5 and uses thereof |
| 07/01/2009 | EP2074146A2 Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor |
| 07/01/2009 | EP2074145A2 Humanized antibody against amyloid beta |
| 07/01/2009 | EP2074144A2 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 07/01/2009 | EP2074143A1 Altered antibodies |
| 07/01/2009 | EP2073897A2 Compositions and methods for modulating tlr14 activity |
| 07/01/2009 | EP2073851A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 07/01/2009 | EP2073844A2 Methods of treating systemic lupus erythematosus |
| 07/01/2009 | EP2073842A2 Use of human cells of myeloid leukaemia origin for expression of antibodies |
| 07/01/2009 | EP1684770B1 Oligo-beta-(1,3)-glucan and monoclonal antibodies against cancer |
| 07/01/2009 | EP1673633B1 Method for detecting feline immunodeficiency virus |
| 07/01/2009 | EP1565208B1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 07/01/2009 | EP1536833B1 Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersina pestis v-antigen |
| 07/01/2009 | EP1527100B1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/01/2009 | EP1377165B1 Tsg101-gag interaction and use thereof |
| 07/01/2009 | EP1351967B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/01/2009 | EP1263939B1 18477, a human protein kinase and uses therefor |
| 07/01/2009 | EP1261704B1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/01/2009 | EP1203025B1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and beta1 integrins |
| 07/01/2009 | EP1111059B1 A novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
| 07/01/2009 | EP1104310B1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 07/01/2009 | EP1019068B1 Therapeutic formulations containing snake and/or insect venom for the prophylaxis and therapy of neoplasms |
| 07/01/2009 | EP0915973B1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 07/01/2009 | CN101472949A Humanized c-Kit antibody |
| 07/01/2009 | CN101472948A Treatment of cancer with anti-IL-1alpha antibodies |
| 07/01/2009 | CN101472947A Methods for high-throughput screening of cell lines |
| 07/01/2009 | CN101472946A Binding molecules |
| 07/01/2009 | CN101469329A Compositions and methods for increasing bone mineralization |
| 07/01/2009 | CN100507567C Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration |
| 07/01/2009 | CN100506847C IgY production for preventing oral cavity disease and tooth paste based on it |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506844C Novel peptides |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/30/2009 | USRE40811 Administering anti-VLA-4 antibody (or anti-VCAM-1 antibody) which blocks binding VLA-4 antigen on surface of CD34 cells to VCAM-1 or fibronectin, thereby increasing number of CD34+ cells in peripheral blood; colony stimulating factors |
| 06/30/2009 | US7554012 Acyltransferases for improving glyphosate and n-acetyl-amino-methyl phosphonate(ampa) resistance |
| 06/30/2009 | US7553956 Nucleotide sequence probes for detecting beer-spoilage lactic acid bacteria; food processing and alcoholic beverages |
| 06/30/2009 | US7553953 For the treatment and diagnosis of various cancers including carcinoma, gastrointestinal, colorectal, colon or ovarian cancer; colon-specific antigen-p mucin (CSAp) antigen |
| 06/30/2009 | US7553939 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 06/30/2009 | US7553938 Purification process of gamma-globulins from human plasma and other sources; using caprylate combined with or replaced by heptanoate to perform precipitation and incubation; anion exchange chromatography |
| 06/30/2009 | US7553937 Specific antibodies for diagnosing heart failure |
| 06/30/2009 | US7553936 Triggering receptors expressed on myeloid cells (TREMs) specific immunoglobulin for use in prevention and treatment of blood coagulation disorders |
| 06/30/2009 | US7553821 Methods for selectively modulating survivin apoptosis pathways |
| 06/30/2009 | US7553814 Cancer drug target; useful in diagnostic, prophylactic, prognostic, of certain cancers |
| 06/30/2009 | US7553811 administering a CD200 fusion protein; tranplant rejection, fetal loss, autoimmune disease, and allergies; immunosuppresant |
| 06/30/2009 | US7553641 Tumour necrosis factor binding ligands |
| 06/30/2009 | US7553630 Detecting metalloproteinase inhibitor in sample of tissue, serum, urine, tumor; detectable label is a monoclonal antibody; radioimmunoassay, enzyme linked immunoassay |
| 06/30/2009 | US7553493 Chlamydia flagellar protein antigen |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | US7553489 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/30/2009 | US7553488 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis |
| 06/30/2009 | US7553486 Anti-VEGF treatment for radiation-induced vasculopathy |
| 06/30/2009 | US7553485 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof |